Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

AMX DATA

Financiado

Cerrado

Identification of risk factors for the development of colorectal cancer and or...

Identification of risk factors for the development of colorectal cancer and or premalignant lesions using Big Data tools and Artifical Intelligence for early cancer detection Founded in 2010, AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is extending people lives, develop... ver más

31/12/2021

ADVANCED MARKER DI...

130K€

Presupuesto del proyecto: 130K€

Líder del proyecto

ADVANCED MARKER DISCOVERY La investigación, el desarrollo, la producción, la comercialización y la distribución e importación de productos biotecnológicos, farmacéuti...

TRL 3-4 | 4M€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-12-31

INNOSUP-02-2019-2020: European SME innovation Associate -...

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ADVANCED MARKER DISCOVERY

129.50K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PTQ2020-010990 VALIDACIÓN CLÍNICA Y ANALÍTICA DE UN TEST DE DETECCIÓN TEMPR... 38K€ Cerrado

ColoFast Developing a Non Invasive Kit for Early Colorectal Cancer De... 3M€ Cerrado

PTQ2019-010421 Desarrollo de un sistema Machine Learning para el análisis u... 82K€ Cerrado

ColoDix Disruptive and high accuracy test for early colorectal cance... 4M€ Cerrado

ACCEPT Artificial Intelligence in Colonoscopy for Cancer Prevention 214K€ Cerrado

AI-MICADIS Artificial Intelligence System for Multi Cancer Detection Su... 71K€ Cerrado

Duración del proyecto: 15 meses Fecha Inicio: 2020-09-15
Fecha Fin: 2021-12-31

Líder del proyecto

ADVANCED MARKER DISCOVERY La investigación, el desarrollo, la producción, la comercialización y la distribución e importación de productos biotecnológicos, farmacéuti...

TRL 3-4 | 4M€

Presupuesto del proyecto 130K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Founded in 2010, AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is extending people lives, developing disruptive technologies to detect the tumor years in advance, before the symptoms appear. The company’s products are oriented to non-invasive early cancer detection, avoiding the complications of existing invasive procedures, as tumor biopsies in colon, lung and pancreatic cancer. The application of Advanced Data Analytical tools in healthcare has a lot of positive and also life-saving potential. When speaking about data, we are referring to the vast quantities of information created in digitization of medical documents, and that could be consolidated and analyzed applying specific technologies. Aligned with our mission, AMADIX continues to go further, not only working at a molecular level but also exploring possibilities that clinical records and patient data offer (particular conditions, lifestyle, living area…). We are registering, processing and analyzing data through the latest Artificial Intelligence (AI) and Advanced Data Analytical Tools, in order to identify new risk factors, to develop predictive models which will help us anticipate hidden underlying cancer risk factors, treat patients in time and help improve the quality of life and survival of cancer patients. So, as an overview, the objective of AMX DATA is identifying risk factors in colon, lung and pancreatic cancer based on medical history, individual habits and image analysis to incorporate new risk cancer factors - in combination with our blood test gene signature - into our algorithms using Big Data tools and Artificial Intelligence. The development of this disruptive project requires the recruitment of an Innovation Associate with a multidisciplinary set of skills combining expertise and knowledge in cancer diagnostics and data analysis tools.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores